Kimberly Esgate
Medical · Thousand Oaks, CANPI 1174166714
Payments from drug & device makers
Across 421 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- Lilly USA, LLC$781
- Biohaven Pharmaceutical Holding Company Ltd.$499
- Novo Nordisk$340
- Abbott$256
- plus $2K from 27 others
What the payments were for
- Travel & lodging$2283%
- Food & beverage$6,94595%
- Education$1492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 149 | $2,409 |
| Amgen | 70 | $1,212 |
| Lilly USA, LLC | 57 | $781 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $499 |
| Novo Nordisk | 22 | $340 |
| Abbott | 11 | $256 |
| Boehringer Ingelheim | 13 | $246 |
| Pfizer | 11 | $233 |
| Currax Pharmaceuticals LLC | 16 | $198 |
| Novartis | 7 | $163 |
| Bayer | 9 | $151 |
| Astellas Pharma US Inc | 2 | $128 |
| Eisai Inc. | 5 | $91 |
| Idorsia Pharmaceuticals US Inc | 5 | $85 |
| Bausch Health US, LLC | 3 | $57 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Merck | 2 | $37 |
| Acerus Pharmaceuticals Corporation | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 3 | $33 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Sanofi | 2 | $31 |
| AstraZeneca | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $23 |
| Heartflow, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Exact Sciences | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$308
- Repatha$229
- KRYSTEXXA$122
How this compares
$7,323 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $50,372 |
| OzempicSemaglutide | 18 | $16,571 |
| JardianceEmpagliflozin | 12 | $14,941 |
| RybelsusSemaglutide | 14 | $13,239 |
| JanuviaSitagliptin Phosphate | 11 | $10,378 |
| EliquisApixaban | 12 | $6,250 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $626 |
| Rosuvastatin Calcium | 61 | $616 |
| Losartan Potassium | 64 | $568 |
| Atorvastatin Calcium | 74 | $491 |
| Levothyroxine Sodium | 49 | $489 |
| Metformin Hcl | 60 | $277 |
| Citalopram HbrCitalopram Hydrobromide | 19 | $273 |
| Gabapentin | 17 | $259 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 21 | $230 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $781 | $50,37244 claims |
| Novo NordiskOzempic, Rybelsus | $340 | $29,81032 claims |
| Boehringer IngelheimJardiance | $246 | $14,94112 claims |
| MerckJanuvia | $37 | $10,37811 claims |
| PfizerEliquis | $233 | $6,25012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.
Other medical in Thousand Oaks
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.